Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling?

Expert Opinion on Therapeutic Targets

Volumn 12, Issue 7, 2008, Pages 905-916

  Maiese, Kenneth ^a   Chong, Zhao Zhong ^a   Shang, Yan Chen ^a   Jinling, Hou ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer; Cardiovascular; Diabetes; Forkhead; FOxo; Immune system; Neurodegeneration; Oxidative stress; Stem cells; Wingless; Wnt

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; WNT PROTEIN;

APOPTOSIS; CANCER GROWTH; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL METABOLISM; CELL PROTECTION; CELL SURVIVAL; DEGENERATIVE DISEASE; DIABETES MELLITUS; GENETIC TRANSCRIPTION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REMISSION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STEM CELL;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 48949116927     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.12.7.905     Document Type: Review

References (100)

1. Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 2005;75(3):207-46
2. Maiese K, Chong ZZ, Shang YC. Raves and risks for erythropoietin. Cytokine Growth Factor Rev 2008;19(2):145-55
3. Hoane MR, Kaplan SA, Ellis AL. The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res 2006;1125(1):185-93
4. Ieraci A, Herrera DG. Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med 2006;3(4):e101. Published online 21 February 2006, doi:10.1371/ journal.pmed.0030101
5. Li F, Chong ZZ, Maiese K. Cell life versus cell longevity: the mysteries surrounding the NAD(+) precursor nicotinamide. Curr Med Chem 2006;13(8):883-95
6. Chong ZZ, Li F, Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 2005;49(1):1-21
7. Cohen SM, Cordeiro-Stone M, Kaufman DG. Early replication and the apoptotic pathway. J Cell Physiol 2007;213(2):434-9
8. Chong ZZ, Li F, Maiese K. The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3β and nuclear factor-κB to foster endogenous microglial cell protection. Int J Mol Med 2007;19(2):263-72
9. Li F, Chong ZZ, Maiese K. Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3β, β-catenin, and nuclear factor-κB. Curr Neurovasc Res 2006;3(3):187-201
10. Mallat M, Marin-Teva JL, Cheret C. Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 2005;15(1):101-7
11. Emami KH, Corey E. When prostate cancer meets bone: control by wnts. Cancer Lett 2007;253(2):170-9
12. Maiese K, Li F, Chong ZZ, Shang YC. The Wnt signaling pathway: Aging gracefully as a protectionist? Pharmacol Ther 2008;118(1):58-81
13. Sauvageot CM, Kesari S, Stiles CD. Molecular pathogenesis of adult brain tumors and the role of stem cells. Neurol Clin 2007;25(4):891-924, vii
14. Speese SD, Budnik V. Wnts. up-and-coming at the synapse. Trends Neurosci 2007;30(6):268-75
15. Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol 2006;21(1):103-24
16. Topol L, Jiang X, Choi H, et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J Cell Biol 2003;162(5):899-908
17. Adachi K, Mirzadeh Z, Sakaguchi M, et al. β-Catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 2007;25(11):2827-36
18. Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 2008;13(3):285-92
19. Kitagawa H, Ray WJ, Glantschnig H, et al. A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling. Mol Cell Biol 2007;27(21):7486-96
20. Castelo-Branco G, Rawal N, Arenas E. GSK-3β inhibition/ β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci 2004;117(Pt 24):5731-7
21. Woll PS, Morris JK, Painschab MS, et al. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008;111(1):122-31
22. Bakre MM, Hoi A, Mong JC, et al. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. J Biol Chem 2007;282(43):31703-12
23. Kwon C, Arnold J, Hsiao EC, et al. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci USA 2007;104(26):10894-9
24. Ai D, Fu X, Wang J, et al. Canonical Wnt signaling functions in second heart field to promote right ventricular growth. Proc Natl Acad Sci USA 2007;104(22):9319-24
25. Zamora M, Manner J, Ruiz-Lozano P. Epicardium-derived progenitor cells require beta-catenin for coronary artery formation. Proc Natl Acad Sci USA 2007;104(46):18109-14
26. Naito AT, Shiojima I, Akazawa H, et al. Developmental stage-specific biphasic roles of Wnt/β-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci USA 2006;103(52):19812-7
27. Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem 2007;14(16):1729-38
28. Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 2007;4(1):63-71
29. Lehman DM, Hunt KJ, Leach RJ, et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 2007;56(2):389-93
30. Guo YF, Xiong DH, Shen H, et al. Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 2006;43(10):798-803
31. Mani A, Radhakrishnan J, Wang H, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007;315(5816):1278-82
32. Al-Aly Z, Shao JS, Lai CF, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-α-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 2007;27(12):2589-96
33. Aslanidi G, Kroutov V, Philipsberg G, et al. Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats. Am J Physiol Endocrinol Metab 2007;293(3):E726-736
34. Chong ZZ, Shang YC, Maiese K. Vascular injury during elevated glucose can be mitigated by esythropoietin and Wnt signaling. Curr Neurovasc Res 2007;4(3):194-204
35. Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008;118(2):526-33
36. Khoshdel A, Carney S, Gillies A, et al. Potential roles of erythropoietin in the management of anaemia and other complications diabetes. Diabetes Obes Metab 2008;10(1):1-9
37. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005;293(1):90-5
38. Tascilar O, Cakmak GK, Tekin IO, et al. Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis. World J Gastroenterol 2007;13(46):6172-82
39. Wu Y, Shang Y, Sun S, et al. Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/ GSK-3β/ caspase-3 mediated signaling pathway. Apoptosis 2007; 12(8):1365-75
40. Hewlett KF, Sakamoto K, Yu H, et al. Insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity is enhanced in human skeletal muscle after exercise. Metabolism 2006;55(8):1046-52
41. Wiedau-Pazos M, Wong E, Solomon E, et al. Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice. Neurobiol Aging 2007. Published online 2 July 2007, doi:10.1016/ j.neurobiolaging.2007.05.015
42. Orlacchio A, Bernardi G, Orlacchio A, Martino S. RNA interference as a tool for Alzheimer's disease therapy. Mini Rev Med Chem 2007;7(11):1166-76
43. Salins P, Shawesh S, He Y, et al. Lovastatin protects human neurons against Aβ-induced toxicity and causes activation of β-catenin-TCF/LEF signaling. Neurosci Lett 2007;412(3):211-6
44. Chong ZZ, Li F, Maiese K. Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal 2007;19(6):1150-62
45. Damjanac M, Rioux Bilan A, Paccalin M, et al. Dissociation of Akt/PKB and ribosomal S6 kinase signaling markets in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2008;29(2):354-67
46. Ishikawa T, Tamai Y, Zorn AM, et al. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 2001;128(1):25-33
47. Dufourcq P, Couffinhal T, Ezan J, et al. FrzA, a secreted frizzled related protein, induced angiogenic response. Circulation 2002;106(24):3097-103
48. Cheng CW, Yeh JC, Fan TP, et al. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. Biochem Biophys Res Commun 2008;365(2):285-90
49. Lobov IB, Rao S, Carroll TJ, et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 2005;437(7057):417-21
50. Lee DK, Nathan Grantham R, Trachte AL, et al. Activation of the canonical Wnt/β-catenin pathway enhances monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 2006;347(1):109-16
51. Tickenbrock L, Schwable J, Strey A, et al. Wnt signaling regulates transendothelial migration of monocytes. J Leukoc Biol 2006;79(6):1306-13
52. Maiese K, Chong ZZ, Shang YC. "Sly as a FOXO": new paths with forkhead signaling in the brain. Curr Neurovasc Res 2007;4(4):295-302
53. Maiese K, Chong ZZ, Shang YC. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol Med 2008;14(5):219-27
54. Jagani Z, Singh A, Khosravi-Far R. FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis. Biochim Biophys Acta 2008;1785(1):63-84
55. Hosaka T, Biggs WH 3rd,Tieu D, et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 2004;101(9):2975-80
56. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are ctitical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007;128(2):325-39
57. Miyamoto K, Araki KY, Naka K, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007;1:101-12
58. Bakker WJ, Van Dijk TB, Parren-Van Amelsvoort M, et al. Differential regulation of Foxo3a target genes in etythropoiesis. Mol Cell Biol 2007;27(10):3839-54
59. Srinivasan S, Anitha M, Mwangi S, Heuckeroth RO. Enteric neuroblasts require the phosphatidylinositol 3-kinase/Akt/Forkhead pathway for GDNF-stimulated survival. Mol Cell Neurosci 2005;29(1):107-19
60. Kim JR, Jung HS, Bae SW, et al. Polymorphisms in FOXO gene family and association analysis with BMI. Obesity (Silver Spring Md) 2006;14(2):188-93
61. Kuningas M, Magi R, Westendorp RG, et al. Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age. Eur J Hum Genet 2007;15(3):294-301
62. Fallarino F, Bianchi R, Orabona C, et al. CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J Exp Med 2004;200(8):1051-62
63. Chong ZZ, Lin SH, Maiese K. The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J Cereb Blood Flow Metab 2004;24(7):728-43
64. Nakamura T, Sakamoto K. Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Mol Cell Endocrinol 2007
65. Chong ZZ, Li F, Maiese K. Erythropoietin requires NF-κB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2005;2(5):387-99
66. Almeida M, Han L, Martin-Millan M, et al. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 2007;282(37):27298-305
67. Won CK, Ji HH, Koh PO. Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci Lett 2006;398(1-2):39-43
68. Chong ZZ, Li F, Maiese K. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and β-Catenin during oxidative stress. Curr Neurovasc Res 2006; 3(2):107-17
69. Chong ZZ, Maiese K. Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br J Pharmacol 2007;150(7):839-50
70. Zheng WH, Kar S, Quirion R. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem 2002;80(6):1049-61
71. Kyoung Kim H, Kyoung Kim Y, Song IH, et al. Down-regulation of a forkhead transcription factor, FOXO3a, accelerates cellular senescence in human dermal fibroblasts. J Gerontol A Biol Sci Med Sci 2005;60(1):4-9
72. Ferrara N, Rinaldi B, Corbi G, et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 2008;11(1):139-50
73. Ludikhuize J, De Launay D, Groot D, et al. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum 2007;56(7):2180-91
74. Kuo CC, Lin SC. Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Mol Med 2007;13(11-12):561-6
75. Bosque A, Aguilo JI, Alava MA, et al. The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling. Blood 2007;109(4):1627-35
76. Sela U, Dayan M, Hershkoviz R, et al. The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses. Eur J Immunol 2006;36(11):2971-80
77. Hur EM, Youssef S, Haws ME, et al. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 2007;8(1):74-83
78. Pohl BS, Knochel W. Overexpression of the transcriptional repressor FoxD3 prevents neural crest formation in Xenopus embryos. Mech Dev 2001;103(1-2):93-106
79. Perreault N, Katz JP, Sackett SD, Kaestner KH. Foxl1 controls the Wnt/ β-catenin pathway by modulating the expression of proteoglycans in the gut. J Biol Chem 2001;276(46):43328-33
80. Balciunaite G, Keller MP, Balciunaite E, et al. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol 2002;3(11):1102-8
81. Ormestad M, Astorga J, Landgren H, et al. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006;133(5):833-43
82. Kimura-Yoshida C, Tian E, Nakano H, et al. Crucial roles of Foxa2 in mouse anterior-posterior axis polarization via regulation of anterior visceral endoderm-specific genes. Proc Natl Acad Sci USA 2007;104(14):5919-24
83. Smith WW, Norton DD, Gorospe M, et al. Phosphorylation of p66Shc and forkhead proteins mediates Aβ toxicity. J Cell Biol 2005; 169(2):331-9
84. Hoogeboom D, Essers MA, Polderman PE, et al. Interaction of FOXO with β-catenin inhibits β-catenin/T cell factor activity. J Biol Chem 2008;283(14):9224-30
85. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002;106(23):2973-9
86. Xu HT, Wei Q, Liu Y, et al. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer. Ann Surg Oncol 2007;14(11):3251-9
87. Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006;66(21):10439-48
88. Tomita H, Yamada Y, Oyama T, et al. Development of gastric tumors in Apc(Min/+) mice by the activation of the β-catenin/Tcf signaling pathway. Cancer Res 2007;67(9):4079-87
89. Perreault N, Sackett SD, Katz JP, et al. Foxl1 is a mesenchymal modifier of Min in carcinogenesis of stomach and colon. Genes Dev 2005;19(3):311-5
90. Sun J, Jin T. Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells. Cell Signal 2008;20(1):219-29
91. Paik JH, Kollipara R, Chu G, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007;128(2):309-23
92. Sunters A, Madureira PA, Pomeranz KM, et al. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res 2006;66(1):212-20
93. Eddy SF, Kane SE, Sonenshein GE. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res 2007;67(19):9018-23
94. Lynch RL, Konicek BW, Mcnulty AM, et al. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol Cancer Res 2005;3(3):163-9
95. Li Y, Wang Z, Kong D, et al. Regulation of FOXO3a/β-catenin/ GSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 2007;282(29):21542-50
96. Yang L, Xie S, Jamaluddin MS, et al. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J Biol Chem 2005;280(39):33558-65
97. Delpuech O, Griffiths B, East P, et al. Induction of Mxil-SRα by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Biol 2007;27(13):4917-30
98. Jacobsen EA, Ananieva O, Brown ML, Chang Y. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene. J Immunol 2006;176(11):6831-8
99. Gomez-Gutierrez JG, Souza V, Hao HY, et al. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol Ther 2006;5(7):875-83
100. Arimoto-Ishida E, Ohmichi M, Mabuchi S, et al. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Endocrinology 2004;145(4):2014-22